CHEST Physician
-
Data support use of nirsevimab prophylaxis to reduce RSV hospitalization risk for infants
Retrospective data show significantly fewer infants were hospitalized for RSV after nirsevimab became available. Among the RSV hospitalizations that occurred during that time period, 75% were in infants who had not received nirsevimab.
-
While still elevated, early 2026 data show US influenza A cases stabilizing or decreasing
Infectious disease expert Frederick G. Hayden, MD, said timely use of antivirals for prophylaxis and treatment can minimize the impact of this flu season, which has seen a significant mismatch between vaccines and the circulating strain.
-
From chalkboards to chatbots: The emerging landscape of AI in medical education
Professors Deepak R. Pradhan, MD, MHPE, FCCP, and Richard M. Schwartzstein, MD, FCCP, discuss the opportunities—and potential pitfalls—of the increasing adoption of artificial intelligence.
-
Beyond the blueprint: Early outcomes from the CHEST Critical Care APP certification exam
The 2025 exam tells a clear story: APPs are seeking meaningful validation, value lifelong learning, and want credentials that reflect the realities of modern critical care.
-
The burden of post-TB lung disease
Post-TB lung disease causes substantial long-term respiratory morbidity, disability, and increased mortality among TB survivors worldwide.
-
Mechanical power as a target for lung protective ventilation
Mechanical power-based strategies aim to minimize unnecessary power delivery and reduce harm. Review how to measure and use this metric and what challenges it poses.
-
New fund empowers CHEST Networks to pursue their most impactful ideas
The Networks Advancement Fund offers financial support for projects that directly advance CHEST’s philanthropic pillars while furthering the mission of an individual Network.
-
Top reads from the CHEST journal portfolio – February 2026
Read new research from the journal portfolio on obesity hypoventilation syndrome treatment, long volume reduction in severe emphysema, and anticoagulation management in cardiogenic shock.
-
Remembering a giant of chest medicine: Alfred Soffer, MD, Master FCCP
Alfred Soffer, MD, Master FCCP, served as Editor in Chief of the journal CHEST® from 1968 to 1993 and led CHEST as its Executive Director from 1969 to 1992.
-
GLP-1RAs may trigger chronic cough for some patients with diabetes
Surprisingly, the association between GLP-1 medications and chronic cough was stronger in patients without an existing diagnosis of gastroesophageal reflux disease.
